76 related articles for article (PubMed ID: 25368255)
1. Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.
Puech C; Prevot N; Perek N
Anticancer Res; 2014 Nov; 34(11):6527-35. PubMed ID: 25368255
[TBL] [Abstract][Full Text] [Related]
2. EGFR inhibition using gefitinib is not active in neuroblastoma cell lines.
Rössler J; Odenthal E; Geoerger B; Gerstenmeyer A; Lagodny J; Niemeyer CM; Vassal G
Anticancer Res; 2009 Apr; 29(4):1327-33. PubMed ID: 19414383
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
[TBL] [Abstract][Full Text] [Related]
4. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor activity determines response of colorectal cancer cells to gefitinib alone and in combination with chemotherapy.
Van Schaeybroeck S; Karaiskou-McCaul A; Kelly D; Longley D; Galligan L; Van Cutsem E; Johnston P
Clin Cancer Res; 2005 Oct; 11(20):7480-9. PubMed ID: 16243822
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
[TBL] [Abstract][Full Text] [Related]
7. High levels of the type III inorganic phosphate transporter PiT1 (SLC20A1) can confer faster cell adhesion.
Kongsfelt IB; Byskov K; Pedersen LE; Pedersen L
Exp Cell Res; 2014 Aug; 326(1):57-67. PubMed ID: 24880124
[TBL] [Abstract][Full Text] [Related]
8. Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Taguchi T; Tsukuda M; Imagawa-Ishiguro Y; Kato Y; Sano D
Oncol Rep; 2008 Jan; 19(1):65-71. PubMed ID: 18097577
[TBL] [Abstract][Full Text] [Related]
9. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines.
Carrasco-García E; Saceda M; Grasso S; Rocamora-Reverte L; Conde M; Gómez-Martínez A; García-Morales P; Ferragut JA; Martínez-Lacaci I
Exp Cell Res; 2011 Jun; 317(10):1476-89. PubMed ID: 21439954
[TBL] [Abstract][Full Text] [Related]
10. PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug.
Wang C; Yang A; Zhang B; Yin Q; Huang H; Chen M; Xie J
Pancreas; 2014 Mar; 43(2):291-7. PubMed ID: 24518510
[TBL] [Abstract][Full Text] [Related]
11. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
Tracy S; Mukohara T; Hansen M; Meyerson M; Johnson BE; Jänne PA
Cancer Res; 2004 Oct; 64(20):7241-4. PubMed ID: 15492241
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib is effective against juvenile pilocytic astrocytoma in vitro.
Foreman NK; Gore L; Wells D; Straessle J; Heideman R; Donson AM
Pediatr Blood Cancer; 2006 Sep; 47(3):293-8. PubMed ID: 16206208
[TBL] [Abstract][Full Text] [Related]
14. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells.
Tamura S; Hosoi H; Kuwahara Y; Kikuchi K; Otabe O; Izumi M; Tsuchiya K; Iehara T; Gotoh T; Sugimoto T
Biochem Biophys Res Commun; 2007 Jun; 358(1):226-32. PubMed ID: 17482563
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.
Wu M; Yuan Y; Pan YY; Zhang Y
Mol Med Rep; 2014 Jun; 9(6):2417-22. PubMed ID: 24682085
[TBL] [Abstract][Full Text] [Related]
17. Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells.
Yu SY; Liu HF; Wang SP; Chang CC; Tsai CM; Chao JI
Chem Biol Interact; 2013 Apr; 203(2):412-22. PubMed ID: 23523951
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines.
Halatsch ME; Gehrke EE; Vougioukas VI; Bötefür IC; A-Borhani F; Efferth T; Gebhart E; Domhof S; Schmidt U; Buchfelder M
J Neurosurg; 2004 Mar; 100(3):523-33. PubMed ID: 15035290
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.
Jones HE; Goddard L; Gee JM; Hiscox S; Rubini M; Barrow D; Knowlden JM; Williams S; Wakeling AE; Nicholson RI
Endocr Relat Cancer; 2004 Dec; 11(4):793-814. PubMed ID: 15613453
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells.
Kitazaki T; Soda H; Doi S; Nakano H; Nakamura Y; Kohno S
Lung Cancer; 2005 Oct; 50(1):19-24. PubMed ID: 16009452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
